michigan glp-1 digestive blockage class action Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1-directed NMDA receptor antagonism for

Unlike GLP-1 agonists that reduce appetite or growth hormone peptides that stimulate lipolysis, the compound addresses fat metabolism at the enzymatic level: it removes the molecular governor that locks adipocytes into a low-energy-expenditure state, potentially restoring normal metabolic function in fat tissue where NNMT is overexpressed

A 2025 pulse survey by the International Foundation of Employee Benefit Plans found most Canadian employers now cover GLP1s for diabetes, but coverage for weightloss indications is far less common and usually comes with conditions such as prior authorization, BMI thresholds and step therapy

#clinicalintegration #advancedprimarycare #glp1 #employeebenefits #workforcehealth #cardiometabolic #obesity #healthcoaching To view or add a comment, sign in The GLP-1 boom has changed the conversationbut it hasn't changed what patients truly need

Ann Intern Med 163 , 4051 (2015)

They quiet the brains hunger signals, slow digestion, and make it easier than ever to eat less

Your doctor may prescribe an anti-nausea medication, or they may even try a different GLP-1 medication or a lower dose